Engineered immunoglobulin-G molecules (IgGs) are of wide interest for the development of detection elements in protein-based biosensors with clinical applications. The strategy usually employed for the de novo design of such engineered IgGs consists on merging fragments of the three-dimensional structure of a native IgG. which is immobilized on the biosensor surface. and of an antibod... https://www.chiggate.com/lovense-lush-3-supply/